Low-Dose Exposure to Bisphenol A in Early Life by Hong, Yeon-Pyo & Yang, Yun-Jung
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 6
Low-Dose Exposure to Bisphenol A in Early Life
Yeon-Pyo Hong and Yun-Jung Yang
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/intechopen.68428
Abstract
Bisphenol A (BPA) has lower estrogenic potency than 17b-estadiol. The reference dose of 
BPA is defined as 50 ug/kg bw/day by the Environmental Protection Agency. The lower 
doses of BPA than no observable effect level are considered safe. However, early life 
exposure to low-dose BPA may increase the risk of developing adult onset disease. 
The harmful effects caused by low-dose BPA in fetus and newborns can transmit to 
third or fourth generations. The suggested mechanism of transgeneration is epigenetic 
changes. In addition, simultaneous exposure to various chemicals can induce combined 
effects. Low-dose effects of BPA are ongoing controversy because the animal test results 
will be the same in humans. Epidemiologic evidences are needed to provide the human 
health effects from exposure to low dose of BPA.
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1. Introduction
Bisphenol A (BPA, CAS #80-05-7) is widely used in manufacturing polycarbonate plastics, 
epoxy resins, and thermal paper including food containers, baby bottles, dental sealant, 
and store receipts. BPA can produce the estrogenic activity through binding with estrogen 
 receptor [1] and can also exert the actions through androgen receptor, peroxisome prolifera-
tor-activated receptor γ, and others [2]. Thus, BPA is classified as an endocrine disruptor (ED)
because of the estrogenic potency.
Traditional toxicology considers that the effect would consistently increase with the amount 
of treatment. The dose levels of BPA below low observed adverse effects level (LOAEL) 
at 50 mg/kg/day [3] are regard as safe. However, recent studies describe the nonmono-
tonic dose response relationship of BPA. Perinatal exposure to lower dose of BPA than 
LOAEL has been reported the harmful effects on endocrine system including reproductive 
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 system [4–7], immune system [8–10], pituitary gland [11–20], and metabolic system [21–24]. 
Because, the fetus and neonates are extremely sensitive to perturbation by hormone like 
chemicals, early life exposure to low dose BPA probably is able to affect the epigenetic 
mechanism. The epigenetic changes caused by BPA may explain the increased risk of devel-
oping adult onset diseases.
The mixed exposure to several low-level EDs should be tested because humans are 
exposed to various EDs simultaneously. Mixture can produce significant adverse effects, 
even when each chemical is present at low doses that individually do not induce observ-
able effects in reproductive system [4, 25] neuroendocrine system [26], and endocrine 
system [27, 28].
Therefore, this chapter describes the harmful effects on adulthood caused by exposure to low-
dose BPA during early life stage.
2. Exposure to bisphenol A
BPA is a chemical compound used to produce polycarbonate plastic and epoxy resins. 
Therefore, humans are exposed to BPA throughout their life. The predominant source of 
BPA exposure to general population is ingestion of food and beverages [29, 30]. Humans 
can also be exposed to BPA through nondietary routes including inhalation [31, 32] and skin 
contact [33].
2.1. Human exposure levels
BPA levels have been measured in human biological samples due to the widespread use 
of BPA-containing products. Unconjugated BPA levels in humans were measured as a 
wide range from 0.2 to 20 ng/ml in serum [32, 34]. BPA also detected in amniotic fluid [35], 
breast milk [36, 37], and maternal amniotic fluid and fetal plasma [38, 39]. These stud-
ies indicate that BPA is able to easily transverse the placental barrier and affect the fetal 
development.
The estimation of BPA exposure in the general population can be based on the presence of 
BPA levels in the biological sample and the amount of daily food intake. Based on urinary 
excretion levels of BPA metabolites, the estimated amounts of BPA in general population are 
up to 0.16-μg/kg body weight (bw) in the USA and 0.04–0.08 μg/kg bw in Japan [40]. Daily 
intake levels of BPA to human have been estimated from 0.2-μg/kg bw/day in 3-month-old 
breasted infants up to 13-μg/kg bw/day in 6-to-12-month-old infants. The estimates of poten-
tial dietary exposure in young children and adults were respectively 5.3 and 1.5 μg/kg bw/day 
based on conservative migration values of BPA and conservative estimates of consumption 
of commercial foods and beverages [41]. This report shows that infants and children are the 
highest intake group because they eat, drink, and breathe more than adults and play or bite 
with the plastic toys.
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2.2. Metabolism
The orally administered BPA could rapidly metabolize to the bisphenol A-glucuronide car-
ried out by the uridine 5′-diphospho-glucuronyl transferase (UGT) in the liver and gut. 
The metabolic process is called as glucuronidation. Unconjugated parent BPA is converted 
into other substances such as sulphate conjugate [37]. The conjugated form of BPA does not 
bind to the estrogen receptors and is excreted in urine [42–44]. It suggests that the conjugates 
have relatively less estrogenic potency than unconjugated form because of the less binding 
affinity to nuclear receptors and rapid excretion. The estimated half-life of BPA was about 6 h 
in the human body [45–47]. In addition, BPA metabolisms in liver cells from rats, mice, and 
humans showed similar pattern across the species [48].
The metabolic process of BPA is different depending on the route of exposure. The highest 
concentration of BPA was measured at 1 h after oral or intraperitoneal administration and at 
4 h after subcutaneous administration [44]. More than 60% of the glucuronidated BPA were 
excreted through urine, and unconjugated form of BPA was mainly excreted in the feces [44]. 
It suggested that the oral route was recommended for appropriated risk assessment of BPA 
because the predominant exposure route of BPA to human is dietary ingestion [40].
In pharmacokinetic studies, BPA metabolites were measured in human urine and blood after 
ingestion of 5 mg deuterated (d6)-BPA [46]. Besides, the maximum unconjugated d6-BPA con-
centration in human serum was detected at 1.6 h after ingestion of the BPA-contained soup [49].
The fetus and newborns are not fully developed in the ability of glucuronidation [50]. 
In experimental studies, neonates showed higher free BPA levels in blood compared to older 
animals when given a same level of BPA [50, 51]. Despite the glucuronidation enzymes have 
not been identified in human, neonates and infants may be vulnerable to BPA exposure com-
pared to adult human.
3. Health effects of low dose bisphenol A
Until recently, the studies on BPA mainly focused on the nuclear mechanisms of estrogen 
response through bind with estrogen receptors (ERs). The binding affinity of BPA to ERβ is 
about 10 times higher than that of ERα [52, 53]. BPA showed 10,000–100,000 weaker estrogenic 
potencies compared to 17β-estradiol [54]. It has been considered that BPA has relatively weak 
estrogenic potency due to the low binding affinity with ERs and the low estrogenic potency 
compared to estradiol.
However, recent studies reported a variety of molecular pathways including androgen 
receptor, aryl hydrocarbon receptor, and peroxisome proliferator-activated receptor, which 
are associated with hormones of the endocrine and other systems in the body [34, 55]. 
The disrupted nuclear hormone receptors can interfere with the secretion and function of 
endocrine system.
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3.1. Low dose effects of bisphenol A
The low dose was defined in the U.S. Environmental Protection Agency (EPA), the National 
Toxicology Program (NTP) assembled a group of scientists in 2001 as any biological effects occur-
ring in the range of typical human exposures or occurring at doses lower than those typically 
used in traditional toxicology assessment [56]. Traditional toxicology considers that the dose 
makes poison. Thus, toxicological studies have been focused on identifying the concentrations at 
which chemicals can cause biological changes, and below that levels are not harmful to health.
According to the definition of NTP, the cutoff doses of low-dose BPA might be the range of 
general public exposure except for occupational exposure and the levels less than 50 mg/kg/
day of LOAEL [3, 54]. However, diethylstilbestrol (DES), which was used to prevent prema-
ture births and miscarriages of pregnant women, is one of the endocrine disruptor and is 
caused endocrine disrupting activity to exposed women and developing babies [57]. Thus, 
the safety levels of EDs may not exist.
Many experimental studies have been reported on low dose effects of BPA [1, 58, 59]. 
Epidemiologic studies also showed that exposure to environmental relevant levels of BPA 
are associated with the disorders in human [60–62]. However, there is still controversy over 
the low-dose effects of BPA because of the difficulty to replicate. Thus, the necessity of the 
reevaluation of human safety daily intake limits is raised.
Low dose is not the same as nonmonotonicity. Monotonic dose response relationship is the 
basic approach in traditional toxicology. In contrast to traditional toxicological approach, 
recent studies suggest that EDs may show the nonmonotonicity including biphasic, U- or 
inverted U-shape dose–response curve (Figure 1) [63]. The lack of monotonic dose-response 
relationship makes it difficult to predict the health effects at low dose using the result from 
high-dose endocrine disruptors.
Exposure to environmental relevant doses of BPA to pregnant mice moved the timing of 
vaginal opening and first estrous cyclicity up in their offspring [58]. BPA below reference 
dose affects the structure and functions of brain through interfering with the hormones and 
neuro hormone receptors [64]. It may be caused by the disruption on brain-gonads-pituitary 
Figure 1. Examples of monotonic and non-monotonic dose response curve.
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gland axis function. However, BPA exposed male and female rats showed no changes of body 
weight, reproductive morphology, and fertility of their female offspring [65].
In epidemiologic studies, the associations were observed between internal BPA concentra-
tions and endocrine hormones. The BPA concentrations in the urine of men in the fertility 
clinic were showed inverse correlation with the estradiol:testosterone ratio [66]. Urinary BPA 
concentrations in human from Italy were positively associated with ERα and ERβ [67].
Recent study showed that BPA at low doses decreased estradiol level and inhibited growth 
of follicles isolated from wild-type and aryl hydrocarbon receptor (AHR) knock-out mice 
through interfering with the AHR [55]. They suggested that AHR signaling pathway might 
not be a major route through BPA exert its toxic effect on ovarian follicles.
The low-dose effects of BPA may associate with the genetic susceptibility, i.e., a gene-environ-
ment interaction. Transgenerational inheritance may associate with the epigenetic changes 
caused by low-dose BPA exposure. Without understanding the gene-environment interac-
tions, there is a limit to understand the low dose effects. Low-dose effects of BPA should be 
validated through epidemiologic studies.
Exposed environmental factors during fetal or neonatal life can interact with the genome 
and influence the onset of diseases in their adulthood including cancer, infertility, precocious 
puberty, and obesity [68]. This theory is called “the developmental origins of health and dis-
ease” [69]. DES, a synthetic estrogen, is well documented that fetal exposure to DES causes the 
severe malformations and cancers of the reproductive tract [57].
Perinatal exposure to low-dose BPA may produce the adverse effects including brain func-
tion, reproduction, pituitary gland, and immunity (Table 1). The harmful effects are per-
sisted and transferred to the fourth generation that was not directly exposed to BPA. BPA 
exposed fetus during their gestational period showed neoplasia and changes in mammary 
tissue [70].
Organ developing period as the first trimester in fetus is the critical period, which means 
they are extremely sensitive to low-dose effects of EDs than adult organisms. Thus, ges-
tational exposure to EDs may induce the harmful effects on the offspring and can trans-
fer to the subsequent generation. This process is called as “epigenetic transgenerational 
inheritance.” The attention has been increasing to the role of epigenetic changes in the 
development of disease because it is considered as one of the mechanisms for explaining of 
low-dose effects.
When epigenetic changes are induced by EDs, those can regulate the gene expression by 
silencing or activating the gene. The mechanisms of regulation are classified as (1) DNA 
methylation, (2) histone modification, and (3) RNA-associated silencing. Because epigenetic 
changes do not modify the gene sequence but affect the gene expression, it may reflect the 
plausible association between exposure to endocrine disruptors and alteration of gene expres-
sion, which resulted into the development of disease.
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Classification Animal model Administration (dose) Exposure duration Effects (offspring) References
Reproductive system Pregnant rats Gavage (50 μg/kg bw/day) GD 6–PND 21 Reduction of semen quality [4]
Reproductive system Medaka (Oryzias 
latipes)
Water tank (200 ng/ml) Lifelong, development, 
neurogenesis, sex 
differentiation
Transgenerational effects [71]
Reproductive system Pregnant rats Drinking water (3 μg/kg bw/
day [estimated average dose of 
exposure])
GD 0–PND 21 Increase LH, estradiol levels 
in serumAbnormal ovary 
histology
[5]
Reproductive system Pregnant rats Gavage (2.5, 25, 260, 2700 ug/
kg bw/day)
GD 6–GD 21 (Dam gavage)/
PND 0–PND 21 (Pup 
gavage)
Alters estrogen receptor 
expression
[7]
Pituitary system/Brain Pregnant rats Gavage (2.5, 25, 2500 μg/kg 
bw/day)
GD 6–GD 21 (Dam gavage)/ 
PND 0–PND 21 (Pup 
gavage)
Effects on anxiety or 
exploratory activity
No consistent effects
[12]
Pituitary system/Brain Pregnant rats Oral (440,400 μg/kg bw/day) GD 6–PND 21 Alters NCS proliferation and 
differentiation
[11]
Pituitary system/Brain Pregnant rats Oral (40 μg/kg bw/day) GD 0–PND 21 Cause anxiety like alteration [13]
Pituitary system/Brain Pregnant rats SC injection (10 μg/kg bw/day) GD 12–PND 21 Disruption in dopamine- and 
serotonin-related genes
[14]
Pituitary system/Brain Pregnant rats Oral (5 μg/kg bw/day) GD 1–PND 100 Adverse development and 
behavior effects on F1 and F2
[17]
Reproduction disorders Pregnant rats Drinking water (3 μg/kg bw/
day [estimated average dose of 
exposure])
GD 0–PND 21 Increase FSH, LH levels in 
serum
Abnormal testis histology
[6]
Pituitary system/Brain Pregnant rats Diet (40 μg/kg bw/day) GD 0–PND 21 Abnormal adrenal histology
Alters the basal and stress 
induced activity
[15]
Pituitary system/Brain Pregnant rats Drinking water (0.1 mg/L BPA) PND 0–PND 21 Alters the ERα signaling and 
behavioral deficit
[16]
Pituitary system/Brain Pregnant rats Gavage (10, 100, 1000, 10,000 
μg/kg bw/day)
GD 10–PND 10 Alters brain development [18]
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Classification Animal model Administration (dose) Exposure duration Effects (offspring) References
Pituitary system/Brain Pregnant rats Gavage (5, 10 μg/kg bw/day) GD 6–GD 21 Alters brain development [19]
Pituitary system/Brain Four week old mice 
(male and female)
Gavage (40, 400 μg/kg bw/day) 8 weeks Sex difference of behaviors: 
locomotion, exploration, 
anxiety, learning-memory in 
adult
[20]
Immune system Pregnant rats Gavage (5 μg/kg bw/day) GD 15–PND 21 Alters immune response [8]
Immune system Pregnant rats Gavage (0.5, 5, 50, 500 μg/kg 
bw/day)
GD 6–PND 21 Induce allergic inflammation [9]
Immune system Pregnant mice Gavage (50 μg/kg bw/day) GD 6–PND 21 Affect immune response [72]
Immune system Pregnant mice Drinking water (10 μg/ml) GD −28 (One week before 
mating)–PND 22
increase the development 
risk of asthma
[10]
Metabolic system Female mice 
(4-week-old)
Diet (50 μg/kg bw/day) Before mating–7 weeks after 
birth
Alters metabolism [21]
Metabolic system Pregnant mice Diet (Prenatal: 0.19, 3.49 μg/kg 
bw/day
Postnatal: 0.36, 7.2 μg/kg bw/
day)
GD 0–PND 21 Control food intake and 
energy expenditure
[22]
Metabolic system Pregnant rats Drinking water (0.01, 0.1, 1.0 
C31 mg/L)
GD 11–PND 21 Increase the preference for 
sweet taste
Sexual difference 
(female>male)
[23]
Metabolic system Pregnant rats Drinking water (1 mg/L BPA 
(estimated 70 μg/kg bw/day))
GD 6–PND 21 Increase adipogenesis: gene 
expression
[24]
Table 1. Low-dose studies of BPA in early life stage.
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3.2. Mixed exposure
Traditional risk assessment approaches are focused on the single chemical. Individual NOAEL 
does not reveal about the possible risk for the multiple exposure of EDs. Simultaneous expo-
sure to multiple endocrine disruptors (mixed exposure) can generate combination effects 
even lower than their NOAEL [73, 74].
The crucial definitions for assessment of mixture exposure are classified as synergisms, antag-
onisms, or additivity: synergism means that the observed effects are stronger than expected; 
likewise, if they are weaker than expectations, there is antagonism. The combination effects 
are similar to the effect of individual agents are called additivism [75].
Combined effects have been reported when treated with mixture of BPA and other EDs 
simultaneously. In vitro studies, synergistic/additive effects are showed in case of simulta-
neous exposure of two or more chemicals [76, 77]. Perinatal exposure to low dose of BPA 
and paraben showed the additive effects on the downregulated semen quality in adult male 
offspring compared to individual exposure [4]. Mixture of BPA and other plastic-derived 
chemicals, despite of higher dose than environmental relevant levels, promoted epigenetic 
transgenerational inheritance of adult onset disease including obesity, testis, and ovary 
disease [78].
4. Conclusion
BPA in daily life are considered safe; however, low-dose effects are observed in experimental 
studies. Early life exposure to low-dose BPA may increase the risk of developing adult onset 
of disease, and the biological changes can transmit to the third or fourth generation. Therefore, 
EFSA propose the tolerable daily intake levels of BPA from 50 to 4-ug/kg bw/day. Low-dose 
effects of BPA are ongoing controversy because of the inconsistent results. Epidemiologic 
evidences such as nested case control studies are needed to provide the human health effects 
caused by exposure to low dose of BPA.
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